Executive Summary
In Q1 of fiscal year 2025, Agilent Technologies Inc reported revenue of $1.681 billion, reflecting a year-on-year increase of 1%. The performance was primarily driven by strong growth in the Food and PFAS markets, as well as a successful launch of the Infinity III series, which bolstered instrument sales. However, management acknowledged headwinds in the Academia and Government segment, experiencing a 7% decline due to reduced federal funding and uncertainties surrounding NIH budgets. Despite these challenges, the company is optimistic about future growth, particularly in the Chinese market where it has secured significant stimulus-related orders. CEO Padraig McDonnell noted, 'We had a very solid start to the year, exceeding our expectations for core revenue growth and EPS.' Overall, the outlook remains cautiously positive as Agilent continues to navigate an evolving economic landscape and implement its Ignite Transformation strategy.
Key Performance Indicators
Revenue
1.68B
QoQ: -1.18% | YoY:1.39%
Gross Profit
901.00M
53.60% margin
QoQ: -1.64% | YoY:-1.31%
Operating Income
376.00M
QoQ: -7.84% | YoY:-6.00%
Net Income
318.00M
QoQ: -9.40% | YoY:-8.62%
EPS
1.12
QoQ: -7.44% | YoY:-5.88%
Revenue Trend
Margin Analysis
Key Insights
- **Revenue**: $1.681 billion, up 1% YoY.
- **Gross Profit**: $901 million, with a gross margin of 53.6%.
- **Operating Income**: $376 million, with operating margins of 22.4%.
- **Net Income**: $318 million, with a net profit margin of 18.9%.
- **EPS**: $1.12, showing a slight decline compared to prior year.